Methods for treatment of diabetes using peptide analogues of insulin
US6197926A · kind A · utility
35Cited by
4References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 23, 1999 |
| Grant date | Mar 6, 2001 |
| Priority date | — |
| Expiry date | Feb 23, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed toward peptide analogues of insulin B chain that are generally derived from peptides comprising residues 9 to 23 of the native B chain sequence. The analogues are altered from the native sequence at position 12, 13, 15 and/or 16, and may be additionally be altered at position 19 and/or other positions. Pharmaceutical compositions containing these peptide analogues arc provided. The peptide analogues are useful for treating and inhibiting the development of diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.